Xiaobai Maimai Plans Entry Into US Radiation Oncology Business

by Shivani Kumaresan, Benzinga Staff Writer

September 28, 2021 11:15 AM | 1 min read |

Chinese social e-commerce platform Xiaobai Maimai Inc HX has announced its plans to enter the radiation oncology services market in the U.S.
Xiaobai recently established We Health Limited, a subsidiary based in New York, to focus on the cancer therapy and radiation oncology business in the U.S.
Xiaobai's Board has appointed Ms. Yilin (Linda) Wang, who has experience in medical health, health management, and medical technology-related businesses, as its Co-Chief Executive Officer.
The company plans to open radiation oncology centers on the East Coast and provide personalized consultation, treatment planning, radiotherapy, and related services to patients with a wide variety of cancers.
Price Action: HX shares are trading lower by 1.06% at $1.86 on the last check Tuesday.

Posted In: News Penny Stocks Movers Trading Ideas Briefs Information Technology IT Consulting & Other Services

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.